RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.20
−2.26%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$5.24
From 52W high−60.28%
Volume1.07M
Market cap$216.28M
P/E (TTM)—
P/S (TTM)1.7x
Div yield—
Key dataSep 18, 2026
Open
$5.24
From 52W high
−60.28%
Volume
1.07M
Market cap
$216.28M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
33.3
MomentumView details →
1D Return
−2.26%
YTD Return
−49.04%
SummaryUpdated Jun 1, 2026
RxSight, Inc. (NASDAQ:RXST) is a medical technology company founded in 1997 and headquartered in Aliso Viejo, California. Originally incorporated as Calhoun Vision, Inc., the company changed its name to RxSight in February 2017 and went public in July 2021. RxSight has developed and commercialized the world's first and only adjustable intraocular lens technology for cataract surgery, allowing surgeons to customize patients' vision after the initial surgical procedure. The company primarily serves the United States market with plans for international expansion into Europe and Asia.
Similar companies
Latest newsMore news →
RxSight, Inc. reported a second-quarter loss of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.21, and compared to a loss of $0.08 per share a year ago.46d agoRxSight granted inducement stock options and restricted stock units to its new President and CEO Aziz Mottiwala in connection with his commencement of employment.56d ago